Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Arrowhead Pharmaceuticals Cash on Hand 2010-2024 | ARWR

Arrowhead Pharmaceuticals cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Arrowhead Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2023 $404
2022 $376
2021 $368
2020 $315
2019 $259
2018 $77
2017 $66
2016 $85
2015 $99
2014 $154
2013 $28
2012 $3
2011 $8
2010 $7
2009 $2
Arrowhead Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $523
2023-12-31 $220
2023-09-30 $404
2023-06-30 $452
2023-03-31 $481
2022-12-31 $502
2022-09-30 $376
2022-06-30 $416
2022-03-31 $402
2021-12-31 $330
2021-09-30 $368
2021-06-30 $516
2021-03-31 $577
2020-12-31 $305
2020-09-30 $315
2020-06-30 $287
2020-03-31 $308
2019-12-31 $502
2019-09-30 $259
2019-06-30 $238
2019-03-31 $218
2018-12-31 $244
2018-09-30 $77
2018-06-30 $60
2018-03-31 $92
2017-12-31 $51
2017-09-30 $66
2017-06-30 $75
2017-03-31 $87
2016-12-31 $102
2016-09-30 $85
2016-06-30 $45
2016-03-31 $61
2015-12-31 $77
2015-09-30 $99
2015-06-30 $111
2015-03-31 $116
2014-12-31 $128
2014-09-30 $154
2014-06-30 $162
2014-03-31 $161
2013-12-31 $76
2013-09-30 $28
2013-06-30 $33
2013-03-31 $3
2012-12-31 $3
2012-09-30 $3
2012-06-30 $2
2012-03-31 $4
2011-12-31 $7
2011-09-30 $8
2011-06-30 $5
2011-03-31 $7
2010-12-31 $5
2010-09-30 $7
2010-06-30 $9
2010-03-31 $3
2009-12-31 $4
2009-09-30 $2
2009-06-30 $2
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.107B $0.241B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.843B 32.06
Chugai Pharmaceutical (CHGCY) Japan $52.640B 23.53
Takeda Pharmaceutical (TAK) Japan $41.776B 8.46
Merck (MKGAF) Germany $23.037B 22.34
Astellas Pharma (ALPMY) Japan $17.355B 27.40
Sandoz Group AG (SDZNY) Switzerland $15.124B 0.00
Neurocrine Biosciences (NBIX) United States $14.145B 38.72
Shionogi (SGIOY) Japan $13.285B 11.55
United Therapeutics (UTHR) United States $12.206B 13.01
Catalent (CTLT) United States $9.947B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.610B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.743B 7.41
Revolution Medicines (RVMD) United States $6.543B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.455B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.168B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.904B 0.00
Summit Therapeutics (SMMT) United States $3.082B 0.00
Corcept Therapeutics (CORT) United States $2.998B 27.17
PTC Therapeutics (PTCT) United States $2.980B 0.00
Dyne Therapeutics (DYN) United States $2.851B 0.00
Indivior (INDV) United States $2.351B 11.14
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.065B 11.74
Catalyst Pharmaceuticals (CPRX) United States $1.952B 19.00
Fusion Pharmaceuticals (FUSN) Canada $1.828B 0.00
Evotec AG (EVO) Germany $1.804B 0.00
Ardelyx (ARDX) United States $1.796B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.753B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.598B 24.02
Avadel Pharmaceuticals (AVDL) Ireland $1.538B 0.00
Soleno Therapeutics (SLNO) United States $1.479B 0.00
Xencor (XNCR) United States $1.466B 0.00
Pacira BioSciences (PCRX) United States $1.438B 13.67
BioCryst Pharmaceuticals (BCRX) United States $1.325B 0.00
4D Molecular Therapeutics (FDMT) United States $1.300B 0.00
Collegium Pharmaceutical (COLL) United States $1.129B 6.75
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Cassava Sciences (SAVA) United States $1.068B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.061B 16.54
Cronos Group (CRON) Canada $1.058B 0.00
Relay Therapeutics (RLAY) United States $1.004B 0.00
USANA Health Sciences (USNA) United States $0.948B 15.51
Ocular Therapeutix (OCUL) United States $0.945B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.864B 0.00
ARS Pharmaceuticals (SPRY) United States $0.856B 0.00
ProKidney (PROK) United States $0.849B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.797B 0.00
Sage Therapeutics (SAGE) United States $0.725B 0.00
Silence Therapeutics (SLN) United Kingdom $0.716B 0.00
Lyell Immunopharma (LYEL) United States $0.665B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.640B 0.00
Savara (SVRA) United States $0.594B 0.00
Harrow (HROW) United States $0.583B 0.00
Exscientia (EXAI) United Kingdom $0.568B 0.00
Altimmune (ALT) United States $0.546B 0.00
Siga Technologies (SIGA) United States $0.538B 6.87
Heron Therapeutics (HRTX) United States $0.518B 0.00
OmniAb (OABI) United States $0.506B 0.00
Larimar Therapeutics (LRMR) United States $0.503B 0.00
Lexeo Therapeutics (LXEO) United States $0.494B 0.00
KalVista Pharmaceuticals (KALV) United States $0.490B 0.00
Bioventus (BVS) United States $0.488B 18.67
Corbus Pharmaceuticals Holdings (CRBP) United States $0.483B 0.00
Korro Bio (KRRO) United States $0.471B 0.00
Verve Therapeutics (VERV) United States $0.465B 0.00
Esperion Therapeutics (ESPR) United States $0.457B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.444B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.372B 0.00
Organogenesis (ORGO) United States $0.367B 69.25
Tourmaline Bio (TRML) United States $0.360B 0.00
Fractyl Health (GUTS) United States $0.349B 0.00
Nanobiotix S.A (NBTX) France $0.335B 0.00
Nektar Therapeutics (NKTR) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 18.89
Xeris Biopharma Holdings (XERS) United States $0.297B 0.00
Aquestive Therapeutics (AQST) United States $0.290B 0.00
Black Diamond Therapeutics (BDTX) United States $0.280B 0.00
ESSA Pharma (EPIX) Canada $0.275B 0.00
Metagenomi (MGX) United States $0.266B 0.00
Foghorn Therapeutics (FHTX) United States $0.265B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.264B 0.00
Akebia Therapeutics (AKBA) United States $0.237B 0.00
Pyxis Oncology (PYXS) United States $0.236B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Eliem Therapeutics (ELYM) United States $0.228B 0.00
Prelude Therapeutics (PRLD) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.221B 0.00
Avita Medical (RCEL) United States $0.210B 0.00
CytoDyn (CYDY) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
Profound Medical (PROF) Canada $0.199B 0.00
Adherex Technologies (FENC) United States $0.195B 237.33
Zevra Therapeutics (ZVRA) United States $0.193B 0.00
Century Therapeutics (IPSC) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.186B 0.00
Achieve Life Sciences (ACHV) Canada $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Incannex Healthcare (IXHL) Australia $0.170B 0.00
Telomir Pharmaceuticals (TELO) United States $0.169B 0.00
MediWound (MDWD) Israel $0.163B 0.00
Elite Pharmaceuticals (ELTP) United States $0.161B 15.05
Rigel Pharmaceuticals (RIGL) United States $0.160B 0.00
Context Therapeutics (CNTX) United States $0.152B 0.00
VAXART, INC (VXRT) United States $0.152B 0.00
Cardiol Therapeutics (CRDL) Canada $0.152B 0.00
Citius Pharmaceuticals (CTXR) United States $0.132B 0.00
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
OptiNose (OPTN) United States $0.131B 0.00
Regulus Therapeutics (RGLS) United States $0.124B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.122B 8.18
FibroGen (FGEN) United States $0.118B 0.00
PMV Pharmaceuticals (PMVP) United States $0.110B 0.00
SCYNEXIS (SCYX) United States $0.101B 1.42
ProPhase Labs (PRPH) United States $0.099B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Relmada Therapeutics (RLMD) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.097B 4.43
AlloVir (ALVR) United States $0.092B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Journey Medical (DERM) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.063B 0.00
Protara Therapeutics (TARA) United States $0.060B 0.00
Carisma Therapeutics (CARM) United States $0.059B 0.00
Inotiv (NOTV) United States $0.055B 0.00
Nutriband (NTRB) United States $0.054B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
CASI Pharmaceuticals (CASI) China $0.041B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
DURECT (DRRX) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Lipocine (LPCN) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.031B 0.00
Surrozen (SRZN) United States $0.031B 0.00
JanOne (JAN) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.80
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
CERo Therapeutics Holdings (CERO) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
SHINECO (SISI) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.63
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 32.64